Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 4 EP applications Young In Timothy Kim has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP16702009

AGONISTIC ICOS BINDING PROTEINS

IPC classification:
A61P 37/00, A61P 31/00, A61P 35/00, C07K 16/28
Applicant:
Aix-Marseille University (Université d'Aix-Marseille)
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Young In Timothy Kim, GlaxoSmithKline
Status:
Request for examination was made
EP16722882

METHOD OF PRODUCING A RECOMBINANT PROTEIN

IPC classification:
C07K 1/14
Applicant:
Glaxo Group Limited
Agent:
Young In Timothy Kim, GlaxoSmithKline
Status:
Request for examination was made
EP16753843

ANTIBODY VARIANTS

IPC classification:
C07K 16/00
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Young In Timothy Kim, GlaxoSmithKline
Status:
Request for examination was made
EP16757967

COMBINATION THERAPY COMPRISING ANTI CTLA-4 ANTIBODIES

IPC classification:
A61P 35/00, A61K 39/395, C07K 16/28
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Young In Timothy Kim, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature